The elevated level of another protein disulfide isomerase, anterior gradient 2 (AGR2), was shown to drive EMT in prostate cancer, which was accompanied by the formation of the aggressive tumor cell phenotype with increased invasive, pro-metastatic, and angiogenic potentials [265]. This evidence concerns the gene AGR2 and prostate carcinoma.